The article “GMO Golden Rice Offers No Nutritional Benefits Says FDAwas published today (Mon 4th June 2018) on Independent Science News. It was written by Allison Wilson, PhD and Jonathan Latham, PhD.
Synopsis: We have previously reported on the difficulties experienced by the Gates-funded Golden Rice project in producing a GMO Golden Rice with adequate yield and agronomic properties. Nevertheless, as widely reported, a version of Golden Rice has recently been permitted for importation by Canada, Australia/New Zealand and now the US. Altogether unnoticed, however, is that the version of Golden Rice approved, called GR2E, contains very little of the key ingredient, beta-carotene. Worse, even the little that it does contain rapidly degrades during storage. For these reasons, FDA has told its developer (the International Rice Research Institute) that no health claims may be based on it. All-told, it seems that the trade-off experienced by the Golden Rice project between beta-carotene production and yield in its various GMO rices has not been resolved.
MORE ON GOLDEN RICE on Independent Science News:
The previous version of GR2 failed due to unintended effects from the modification process and the mis-expressed transgene:
Excellent article about the GR failures and the many Golden Rice implementation challenges:
Analysis by a Vitamin A nutrition expert on why Golden Rice is poor solution — even assuming a high yielding, high-beta-carotene version were possible: